Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations

Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations

Landmark molecular profiling efforts have identified multiple targetable alterations in cholangiocarcinoma. Among the molecular-driven subsets of cholangiocarcinoma, targeting the fibroblast growth factor receptor (FGFR) has shown promise and represents the first targeted therapy to be approved in t...

Full description

Bibliographic Details
Main Authors: Patrick C. Lee, Andrew Hendifar, Arsen Osipov, May Cho, Daneng Li, Jun Gong
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
cholangiocarcinoma
fibroblast growth factor receptor (FGFR)
pemigatinib
infigratinib
derazantinib
debio 1347
Online Access:https://www.mdpi.com/2072-6694/13/7/1706

Internet

https://www.mdpi.com/2072-6694/13/7/1706

Similar Items